• Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23685455; PubMed=25538140).
  

PubMed=23685455; DOI=10.1038/nature12154
Joanna Kaplon, Liang Zheng, Katrin Meissl, Barbara Chaneton, Vitaly A. Selivanov, Gillian Mackay, Sjoerd H. van der Burg, Elizabeth M.E. Verdegaal, Marta Cascante, Tomer Shlomi, Eyal Gottlieb, Daniel S. Peeper;
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence.
Nature 498:109-112(2013)

PubMed=25502142; DOI=10.1038/ncomms6712; PMCID=PMC4428333
Judith Muller, Oscar Krijgsman, Jennifer Tsoi, Lidia Robert, Willy Hugo, Chunying Song, Xiang-Ju Kong, Patricia Abrao Possik, Paulien D.M. Cornelissen-Steijger, Marnix H. Geukes Foppen, Kristel Kemper ...Show all 19 authors... , Colin Ronald Goding, Ultan McDermott, Christian Blank, John B.A.G. Haanen, Thomas G. Graeber, Antoni Ribas, Roger S. Lo, Daniel S. Peeper; Show fewer authors
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
Nat. Commun. 5:5712.1-5712.15(2014)

PubMed=25538140; DOI=10.15252/msb.20145450; PMCID=PMC4300494
Marjon A. Smit, Gianluca Maddalo, Kylie Greig, Linsey M. Raaijmakers, Patricia Abrao Possik, Bas van Breukelen, Salvatore Cappadona, Albert J.R. Heck, A.F. Maarten Altelaar, Daniel S. Peeper;
ROCK1 is a potential combinatorial drug target for BRAF mutant melanoma.
Mol. Syst. Biol. 10:772-772(2014)